French pharmaceutical and healthcare company Sanofi on Friday announced a share buyback plan worth up to €2 billion ($2.08 ...

Sanofi (SNY), a French pharmaceutical and healthcare company, Friday announced that it is executing the second tranche of its share ...

French healthcare company Sanofi announced on Friday a share buyback plan worth up to 2 billion euros ($2.1 billion), which ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

In other deals, Linklaters, Willkie and Latham are advising as PAI Partners negotiates to buy a stake in Alvest, a France-based provider of ground support equipment for airports, in a deal worth an ...

L’Oréal remains an important shareholder of Sanofi and is fully supportive of the company’s value creation strategy,” said ...

European markets closed at record highs Thursday as investors reacted to the European Central Bank’s fifth consecutive ...

Sanofi CFO François Roger signals increased M&A activity, eyes China for innovation, as company expects cash from Opella sale ...

France Calls for ‘Massive’ Regulatory Pause as Economy Flags French push comes as US President Trump moves to deregulate EU is under growing pressure from industry to cut red tape ...

The French paper adds pressure on the European Union, which has already said it plans to make regulatory simplification a key part of its agenda for the next five years. In a draft report due next ...

French push comes as US President Trump moves to deregulate EU is under growing pressure from industry to cut red tape France is calling for a major reworking of European regulations, starting with ...